PHARMACEUTICAL COMPOSITION FOR INHIBITION OF INTERLEUKIN-2- -DEPENDENT TUMOR CELLS PROLIFERATION, γ--INTERFERON CONTENT INCREASE, TREATMENT OF PATIENTS WITH INTESTINE INFLAMMATORY DISEASES, INHIBITION POTENTIATION OF CYTOKINE PRODUCTION AND LIMITATION OR INHIBITION OF ALLERGIC RESPONSE OF DELAYED TYPE Russian patent published in 1998 - IPC

FIELD: medicine, pharmacy. SUBSTANCE: pharmaceutical composition has at least one pharmaceutically acceptable carrier and an active substance taken from a group involving interleukin-4, interleukin-10, combination of interleukin-4 and interleukin-10 and antibodies against interleukin-4 and interleukin-10 taken at an effective amount. EFFECT: enhanced effectiveness of composition. 6 cl, 14 tbl